The Use Of A Potential Novel Tool In Virtual Crossmatching For Platelet Transfusion In Platelet Refractoriness

Background and Objectives: Transfusion support for immune-mediated platelet refractoriness (PR) is clinically challenging, technically laborious and costly. The development of 'EpHLA/EpVix software' has been used successfully to select kidney donors. Here, we sought to evaluate this new software as a tool for platelet virtual crossmatch (VxM). Materials and Methods: This is a prospective study from 2007 to 2014 of PR patients in a tertiary hospital. Platelet components selected by HLAMatchmaker program were crossmatched by EpHLA/EpVix, anti-human globulin complement-dependent lymphocytotoxicity test (AHG-CDC), flow cytometry platelet crossmatch (FCxM) and then compared. Effectiveness of platelet components transfused was evaluated by CCI. Results: Ninety-seven crossmatched platelet transfusions for 27 patients were enrolled. Partial matches were analysed for 75 transfusions by the 3 methods, and 22% showed discrepant results among the assays. After further analysis, data showed that all divergent cases could be explained by HPA alloimmunization, prozone effect (FCxM), low sensitivity of AHG-CDC and possible interference in FCxM/AHG-CDC assays. Notably, sensitivity and specificity of VxM analysis was excellent (100%). Satisfactory CCI counts were obtained for the majority (22/30) of the transfusions. Conclusion: The new EpHLA/EpVix method showed to be effective, feasible and fast for VxM at no cost and able to minimize labour on donor identification. However, platelet crossmatching may be a necessary step because EpHLA/EpVix does not formally exclude HPA alloimmunization. © 2016 International Society of Blood Transfusion.11017078Hod, E., Schwartz, J., Platelet transfusion refractoriness (2008) Br J Haematol, 142, pp. 348-360Davis, K.B., Slichter, S.J., Corash, L., Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution (1999) Transfusion, 39, pp. 586-592Rebulla, P., Formulae for the definition of refractoriness to platelet transfusion (1993) Transfus Med, 3, pp. 91-93Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group (1997) N Engl J Med, 337, pp. 1861-1869Zimring, J.C., Welniak, L., Semple, J.W., Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group (2011) Transfusion, 51, pp. 435-441Rebulla, P., Refractoriness to platelet transfusion (2002) Curr Opin Hematol, 9, pp. 516-520Rebulla, P., A mini-review on platelet refractoriness (2005) Haematologica, 90, pp. 247-253Pavenski, K., Freedman, J., Semple, J.W., HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management (2012) Tissue Antigens, 79, pp. 237-245Bub, C.B., Martinelli, B.M., Avelino, T.M., Platelet antibody detection by flow cytometry: an effective method to evaluate and give transfusional support in platelet refractoriness (2013) Rev Bras Hematol Hemoter, 35, pp. 252-255Schiffer, C.A., Keller, C., Dutcher, J.P., Potential HLA-matched platelet donor availability for alloimmunized patients (1983) Transfusion, 23, pp. 286-289Meehan, K.R., Matias, C.O., Rathore, S.S., Platelet transfusions: utilization and associated costs in a tertiary care hospital (2000) Am J Hematol, 64, pp. 251-256Duquesnoy, R.J., Filip, D.J., Rodey, G.E., Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients (1977) Am J Hematol, 2, pp. 219-226Yankee, R.A., Grumet, F.C., Rogentine, G.N., Platelet transfusion The selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing (1969) N Engl J Med, 281, pp. 1208-1212Brooks, E.G., MacPherson, B.R., Fung, M.K., Validation of HLAMatchmaker algorithm in identifying acceptable HLA mismatches for thrombocytopenic patients refractory to platelet transfusions (2008) Transfusion, 48, pp. 2159-2166Pai, S.C., Lo, S.C., Lin Tsai, S.J., Epitope-based matching for HLA-alloimmunized platelet refractoriness in patients with hematologic diseases (2010) Transfusion, 50, pp. 2318-2327Sousa, L.C., Filho, H.L., Von Glehn Cde, Q., EpHLA: an innovative and user-friendly software automating the HLAMatchmaker algorithm for antibody analysis (2011) Transpl Immunol, 25, pp. 210-216Robinson, J., Waller, M.J., Fail, S.C., The IMGT/HLA database (2009) Nucleic Acids Res, 37, pp. D1013-D1017Saber, W., Opie, S., Rizzo, J.D., Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia (2012) Blood, 119, pp. 3908-3916Filho, H.L., da Mata Sousa, L.C., von Glehn Cde, Q., EpHLA software: a timesaving and accurate tool for improving identification of acceptable mismatches for clinical purposes (2012) Transpl Immunol, 26, pp. 230-234Takemoto, S., Port, F.K., Claas, F.H., HLA matching for kidney transplantation (2004) Hum Immunol, 65, pp. 1489-1505Jin, Y., Dietz, H.C., Nurden, A., Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa (1993) Blood, 82, pp. 2281-2288Schuh, A.C., Watkins, N.A., Nguyen, Q., A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens (2002) Blood, 99, pp. 1692-1698Skogen, B., Bellissimo, D.B., Hessner, M.J., Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers (1994) Transfusion, 34, pp. 955-960Kiefel, V., The MAIPA assay and its applications in immunohaematology (1992) Transfus Med, 2, pp. 181-188Kiefel, V., Santoso, S., Weisheit, M., Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies (1987) Blood, 70, pp. 1722-1726Johnson, A.H., Rossen, R.D., Butler, W.T., Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection (1972) Tissue Antigens, 2, pp. 215-226Roy, T., Garner, S., Shenton, B.K., Further clinical applications (2000) Flow Cytometry, pp. 99-124. , in: Ormerod M (ed): Oxford, UK, Oxford University PressDuquesnoy, R.J., Clinical usefulness of HLAMatchmaker in HLA epitope matching for organ transplantation (2008) Curr Opin Immunol, 20, pp. 594-601Duquesnoy, R.J., A structurally based approach to determine HLA compatibility at the humoral immune level (2006) Hum Immunol, 67, pp. 847-862R: A language and environment for statistical computing. 2014. (2014) R Core Team, , http://www.R-project.org/Landsteiner, K., van der Scheer, J., On the specificity of serological reactions with simple chemical compounds (inhibition reactions) (1931) J Exp Med, 54, pp. 295-305Butch, A.W., Dilution protocols for detection of hook effects/prozone phenomenon (2000) Clin Chem, 46, pp. 1719-1721Bray, R.A., Tarsitani, C., Gebel, H.M., Clinical cytometry and progress in HLA antibody detection (2011) Methods Cell Biol, 103, pp. 285-310Rodey, G., Bollig, B., Oldfather, J., Extra reactivities detected in flow-cytometry-positive, CDC-negative crossmatches are definable HLA specificities (1987) Transplant Proc, 19, pp. 778-779Sanchez-Mazas, A., Meyer, D., The relevance of sequencing in population genetics studies (2014) J Immunol Res, 2014, p. 971818Abbas, A.K., Lichtman, A., (2007) Cellular and Molecular Immunology, , ed 6th. Philadelphia: Saunders;Sagiroglu, T., Tozkir, H., Kilicarslan-Ayna, T., Is flow cytometry crossmatch analysis using sera with different dilutions important for pretransplant analysis? A case report (2012) Transplant Proc, 44, pp. 1767-1769Kosmoliaptsis, V., Bradley, J.A., Peacock, S., Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies (2009) Transplantation, 87, pp. 813-82